Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jit Sarkar

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Science Advances|November 24, 2023
Coherent light control of a metastable hidden stateJulian Maklar, Jit Sarkar, Shuo Dong, et al.
Science Translational Medicine|August 6, 2025
An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancerMeriem Bahri, Taha Al-Adhami, Emre Demirel, et al.
JCI Insight|July 8, 2025
Tumor microenvironments with an active type I IFN response are sensitive to inhibitors of heme degradationDominika Sosnowska, Tik Shing Cheung, Jit Sarkar, et al.
Elife|April 20, 2021
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2Salwa Naushin, Viren Sardana, Rajat Ujjainiya, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Science Advances|November 24, 2023
Coherent light control of a metastable hidden stateJulian Maklar, Jit Sarkar, Shuo Dong, et al.
Science Translational Medicine|August 6, 2025
An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancerMeriem Bahri, Taha Al-Adhami, Emre Demirel, et al.
JCI Insight|July 8, 2025
Tumor microenvironments with an active type I IFN response are sensitive to inhibitors of heme degradationDominika Sosnowska, Tik Shing Cheung, Jit Sarkar, et al.
Elife|April 20, 2021
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2Salwa Naushin, Viren Sardana, Rajat Ujjainiya, et al.
Pageof 5